Association Between Uric Acid and Insulin-Like Growth Factor-1 in Type 2 Diabetes Mellitus

References

• Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
   PubMed Web of Science ®Google Scholar
• Aguirre GA, De Ita JR, de la Garza RG, et al. Insulin-like growth factor-1 deficiency and metabolic syndrome. J Transl Med. 2016;14:3. doi:10.1186/s12967-015-0762-z
   PubMed Web of Science ®Google Scholar
• Boulware SD, Tamborlane WV, Rennert NJ, et al. Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults. J Clin Invest. 1994;93(3):1131–1139. doi:10.1172/JCI117065
   PubMed Web of Science ®Google Scholar
• Miyake H, Kanazawa I, Sugimoto T. Decreased serum insulin-like growth factor-I level is associated with the increased mortality in type 2 diabetes mellitus. Endocr J. 2016;63(9):811–818. doi:10.1507/endocrj.EJ16-0076
   PubMed Web of Science ®Google Scholar
• Moses AC, Young SC, Morrow LA, et al. Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes. 1996;45(1):91–100. doi:10.2337/diab.45.1.91
   PubMed Web of Science ®Google Scholar
• Thrailkill KM. Insulin-like growth factor-I in diabetes mellitus: its physiology, metabolic effects, and potential clinical utility. Diabetes Technol Ther. 2000;2(1):69–80. doi:10.1089/152091599316775
   PubMedGoogle Scholar
• Maggio M, De Vita F, Lauretani F, et al. IGF-1, the cross road of the nutritional, inflammatory and hormonal pathways to frailty. Nutrients. 2013;5(10):4184–4205. doi:10.3390/nu5104184
   PubMed Web of Science ®Google Scholar
• Underwood LE, Clemmons DR, Maes M, et al. Regulation of somatomedin-C/insulin-like growth factor I by nutrients. Horm Res. 1986;24(2–3):166–176. doi:10.1159/000180556
   PubMedGoogle Scholar
• Bobulescu IA, Moe OW. Renal transport of uric acid: evolving concepts and uncertainties. Adv Chronic Kidney Dis. 2012;19(6):358–371. doi:10.1371/journal.pone.0078284
   PubMed Web of Science ®Google Scholar
• Hayden MR, Tyagi SC. Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutr Metab. 2004;1(1):10. doi:10.1186/1743-7075-1-10
   Google Scholar
• Yu S, Chen Y, Hou X, et al. Serum uric acid levels and diabetic peripheral neuropathy in type 2 diabetes: a systematic review and meta-analysis. Mol Neurobiol. 2016;53(2):1045–1051. doi:10.1007/s12035-014-9075-0
   PubMed Web of Science ®Google Scholar
• Hou L, Shi Y, Wang S, et al. Associations of serum uric acid level with diabetic retinopathy and albuminuria in patients with type 2 diabetes mellitus. J Int Med Res. 2020;48(12):1220763532. doi:10.1177/0300060520963980
   Web of Science ®Google Scholar
• De Cosmo S, Viazzi F, Pacilli A, et al. Serum uric acid and risk of CKD in type 2 diabetes. Clin J Am Soc Nephrol. 2015;10(11):1921–1929. doi:10.2215/CJN.03140315
   PubMed Web of Science ®Google Scholar
• Beydoun MA, Fanelli-Kuczmarski MT, Canas J-A, et al. Dietary factors are associated with serum uric acid trajectory differentially by race among urban adults. Br J Nutr. 2018;120(8):935–945. doi:10.1017/S0007114518002118
   PubMed Web of Science ®Google Scholar
• Serrano VC, Lopez GJ, Garcia CS, et al. Influence of nutritional status on hospital length of stay in patients with type 2 diabetes. Endocrinol Diabetes Nutr. 2020;67(10):617–624. doi:10.1016/j.endinu.2020.05.004
   Web of Science ®Google Scholar
• Ni W, Wang R, Liu Z, et al. Association of serum uric acid with metabolic syndrome and its components: a Cross-Sectional Study in Chinese Coastal Population. Metab Syndr Relat Disord. 2020;18(2):103–109. doi:10.1089/met.2019.0043
   PubMed Web of Science ®Google Scholar
• King C, Lanaspa MA, Jensen T, et al. Uric acid as a cause of the metabolic syndrome. Contrib Nephrol. 2018;192:88–102. doi:10.1159/000484283
   PubMed Web of Science ®Google Scholar
• Wang P, Ji B, Shao Q, et al. Association between insulin-like growth factor-1 and uric acid in Chinese children and adolescents with idiopathic short stature: a Cross-Sectional Study. Biomed Res Int. 2018;2018:4259098. doi:10.1155/2018/4259098
   PubMed Web of Science ®Google Scholar
• Sesti G, Hribal ML, Procopio T, et al. Low circulating insulin-like growth factor-1 levels are associated with high serum uric acid in nondiabetic adult subjects. Nutr Metab Cardiovasc Dis. 2014;24(12):1365–1372. doi:10.1016/j.numecd.2014.06.012
   PubMed Web of Science ®Google Scholar
• Grimaldi A, Heurtier A. Diagnostic criteria for type 2 diabetes. Rev Prat. 1999;49(1):16–21.
   PubMedGoogle Scholar
• Isojima T, Shimatsu A, Yokoya S, et al. Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method. Endocr J. 2012;59(9):771–780. doi:10.1507/endocrj.ej12-0110
   PubMed Web of Science ®Google Scholar
• Arersa KK, Wondimnew T, Welde M, et al. Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients attending Jimma Medical Center, Southwestern Ethiopia, 2019. Diabetes Metab Syndr Obes. 2020;13:2059–2067. doi:10.2147/DMSO.S252825
   PubMed Web of Science ®Google Scholar
• Multidisciplinary Expert Task Force on Hyperuricemia and Related Diseases. Chinese multidisciplinary expert consensus on the diagnosis and treatment of hyperuricemia and related diseases. Chin Med J. 2017;130(20):2473–2488. doi:10.4103/0366-6999.216416
   PubMed Web of Science ®Google Scholar
• Facchini F. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA. 1991;266(21):3008–3011. doi:10.1001/jama.1991.03470210076036
   PubMed Web of Science ®Google Scholar
• Purifine AS, Ekou FK, Konan YE, et al. Dietary habits among type 2 diabetic patients attending the Abidjan Diabetes Centre. Sante Publique (Paris). 2017;29(3):423–430.
   Web of Science ®Google Scholar
• Jia L, Xing J, Ding Y, et al. Hyperuricemia causes pancreatic beta-cell death and dysfunction through NF-kappaB signaling pathway. PLoS One. 2013;8(10):e78284. doi:10.1371/journal.pone.0078284
   PubMed Web of Science ®Google Scholar
• Zhu Y, Hu Y, Huang T, et al. High uric acid directly inhibits insulin signalling and induces insulin resistance. Biochem Biophys Res Commun. 2014;447(4):707–714. doi:10.1016/j.bbrc.2014.04.080
   PubMed Web of Science ®Google Scholar
• Ji S, Guan R, Frank SJ, et al. Insulin inhibits growth hormone signaling via the growth hormone receptor/JAK2/STAT5B pathway. J Biol Chem. 1999;274(19):13434–13442. doi:10.1074/jbc.274.19.13434
   PubMed Web of Science ®Google Scholar